Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre - PubMed (original) (raw)

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre

R J van Oostenbrugge et al. J Neurol Neurosurg Psychiatry. 2006 Mar.

Abstract

The aim of this study was to describe the clinical experience in 184 consecutive stroke patients first-ever treated with recombinant tissue plasminogen activator (rt-PA) at a single Dutch centre, with special emphasis on results among the very old. Outcome parameters were the modified Rankin scale (mRs) at 3 months and symptomatic intracranial haemorrhage (SICH). Outcome was related to age. A total of 184 patients were treated of whom 45 were 80 years of age or older (24%). Sixty two (45%) of 139 patients < 80 years of age and 12 (27%) of 45 patients > or = 80 years of age had a favourable outcome defined as an mRs score of 0 or 1 (OR 2.21; 95% CI: 1.06 to 4.46). There was a good outcome (mRs score < or = 2) in 88 (63%) and 16 (36%) patients, respectively (OR 3.13; 95% CI: 1.55 to 6.30). SICH was observed in four of 139 (2.9%) patients < 80 years of age and in five of 45 (11.1%) patients > or = 80 years of age (OR 4.22; 95% CI: 1.08 to 16.46). The results of this study underline the uncertainty regarding the risk/benefit ratio of rt-PA treatment in acute stroke in patients over 80 years of age.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

Comment in

• Is old age really a reason to withhold thrombolytic therapy?
  Schwark C, Schellinger PD. Schwark C, et al. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):289. doi: 10.1136/jnnp.2005.080192. J Neurol Neurosurg Psychiatry. 2006. PMID: 16484633 Free PMC article.

Similar articles

• Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
  Al-Khaled M, Matthis C, Eggers J. Al-Khaled M, et al. J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11. J Stroke Cerebrovasc Dis. 2014. PMID: 22578915
• Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
  Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K. Mori M, et al. Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22854333
• The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
  Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD. Sobesky J, et al. Cerebrovasc Dis. 2007;24(1):56-65. doi: 10.1159/000103117. Epub 2007 May 22. Cerebrovasc Dis. 2007. PMID: 17519545 Clinical Trial.
• Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
  Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G. Roveri L, et al. J Stroke Cerebrovasc Dis. 2013 Aug;22(6):703-8. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.003. Epub 2011 Nov 30. J Stroke Cerebrovasc Dis. 2013. PMID: 22133742
• Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
  Seet RC, Rabinstein AA. Seet RC, et al. Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.

Cited by

• Stroke in Frail Older People.
  Smithard DG. Smithard DG. Geriatrics (Basel). 2017 Jul 15;2(3):24. doi: 10.3390/geriatrics2030024. Geriatrics (Basel). 2017. PMID: 31011034 Free PMC article.
• Contraindications to intravenous rtPA for acute stroke: A critical reappraisal.
  Fugate JE, Rabinstein AA. Fugate JE, et al. Neurol Clin Pract. 2013 Jun;3(3):177-185. doi: 10.1212/CPJ.0b013e318296f0a9. Neurol Clin Pract. 2013. PMID: 29473642 Free PMC article.
• Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.
  Fugate JE, Rabinstein AA. Fugate JE, et al. Neurohospitalist. 2015 Jul;5(3):110-21. doi: 10.1177/1941874415578532. Neurohospitalist. 2015. PMID: 26288669 Free PMC article. Review.
• Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
  Matsuo R, Kamouchi M, Fukuda H, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators. Matsuo R, et al. PLoS One. 2014 Oct 16;9(10):e110444. doi: 10.1371/journal.pone.0110444. eCollection 2014. PLoS One. 2014. PMID: 25329379 Free PMC article.
• Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke.
  Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM. Chapman SN, et al. Vasc Health Risk Manag. 2014 Feb 24;10:75-87. doi: 10.2147/VHRM.S39213. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24591838 Free PMC article. Review.

References

1. 1. The NINDS rt‐PA Stroke Study Group Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 19953331581–1587. - PubMed
2. 1. Wardlaw J M, Del Zoppo G, Yamaguchi T.et al Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003(3)CD 000213 - PubMed
3. 1. Warlow C P, Wardlaw J M. Therapeutic thrombolysis for acute ischemic stroke. BMJ 2003326233–234. - PMC - PubMed
4. 1. Lindley R I, Wardlaw J M, Sandercock P A G. Alteplase and ischaemic stroke: have new reviews of old data helped? Lancet Neurol 20054254–257. - PubMed
5. 1. Chiu D, Krieger D, Villar‐Cordova C.et al Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 19982918–22. - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central